Infrared Spectroscopy Devices Market Size, Share, Growth, and Industry Analysis, By Type (Bench Top,Portable), By Application (Hospitals and Clinics,Pharmaceutical Industry,Research Laboratories), Regional Insights and Forecast to 2035

Infrared Spectroscopy Devices Market Overview

The global Infrared Spectroscopy Devices size is projected to grow from USD 1417.33 million in 2026 to USD 1495.43 million in 2027, reaching USD 2306.34 million by 2035, expanding at a CAGR of 5.51% during the forecast period.

The Infrared Spectroscopy Devices Market processed over 7.8 million units globally in 2024, with bench top systems contributing 61% and portable systems representing 39%. Around 42% of devices were applied in the pharmaceutical sector, 33% in hospitals and clinics, and 21% in research laboratories. More than 54% of installations worldwide supported drug discovery projects, while 28% were integrated into diagnostic applications. Around 17% of devices were deployed for agricultural and food testing. By 2024, nearly 1.2 million units were installed in North America, 2.3 million units in Asia-Pacific, 2.1 million units in Europe, and 0.9 million units in the Middle East & Africa.

The USA accounted for 870,000 units of infrared spectroscopy devices in 2024, representing 11% of global installations. Around 46% of U.S. demand came from hospitals and clinics, equal to 400,200 units, while 32% was applied in pharmaceutical research, totaling 278,400 units. Research laboratories accounted for 19% with 165,000 devices. More than 65% of devices used in the U.S. were bench top systems, while 35% were portable. Approximately 39% of American hospitals incorporated IR devices for diagnostic testing. Around 27% of pharmaceutical companies in the U.S. deployed infrared spectroscopy devices for quality assurance. These facts reinforce the leadership of the USA in the Infrared Spectroscopy Devices Market Outlook.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 54% growth driven by pharmaceutical sector, 28% by diagnostics, 12% by academic research, and 6% by food testing.
• Major Market Restraint: 41% high device cost, 27% lack of technical expertise, 21% limited adoption in SMEs, 11% regulatory delays.
• Emerging Trends: 37% rise in portable adoption, 29% AI-based integration, 18% miniaturization, 16% cloud-enabled data analysis.
• Regional Leadership: 29% Asia-Pacific, 27% Europe, 25% North America, 19% Middle East & Africa.
• Competitive Landscape: 34% controlled by top 3 firms, 28% by mid-sized players, 22% by regional suppliers, 16% by startups.
• Market Segmentation: 61% bench top, 39% portable; 42% pharmaceutical, 33% hospitals, 21% research laboratories.
• Recent Development: 38% portable device launches, 26% AI-based solutions, 22% research-focused models, 14% hospital integrations.

Infrared Spectroscopy Devices Market Latest Trends

The Infrared Spectroscopy Devices Market has seen rapid expansion of portable systems, which grew by 37% in 2024 with 1.5 million new installations worldwide. Around 29% of devices launched incorporated AI-based software, reducing testing time by 23%. Miniaturization advanced further, with 18% of newly introduced devices weighing under 1.2 kg compared to 3.5 kg previously. Around 16% of devices shipped in 2024 included cloud-enabled connectivity, enabling remote diagnostics and data sharing.

In the pharmaceutical industry, 42% of quality assurance labs employed infrared spectroscopy devices, equivalent to 3.2 million units globally. Around 27% of hospitals in Europe integrated infrared systems for real-time patient diagnostics. Asia-Pacific contributed 34% of demand in research laboratories, with China and India leading installations. In the Middle East & Africa, 19% of new purchases came from oil and gas applications where infrared spectroscopy identified hydrocarbon compounds. These facts confirm strong Infrared Spectroscopy Devices Market Trends and highlight expansion opportunities across healthcare, pharmaceuticals, and industrial research sectors.

Infrared Spectroscopy Devices Market Dynamics

DRIVER

"Rising demand in the pharmaceutical sector"

The pharmaceutical industry accounted for 42% of global infrared spectroscopy device demand in 2024, equal to 3.2 million units. Around 58% of these devices were used for drug discovery and molecular analysis, while 29% were applied in quality assurance testing. More than 19% of pharmaceutical companies integrated portable infrared devices for real-time batch testing. North America represented 33% of pharmaceutical usage, Europe 29%, and Asia-Pacific 28%. Hospitals also accounted for 1.9 million device installations in diagnostic labs. These numbers confirm pharmaceuticals as the largest driver of Infrared Spectroscopy Devices Market Growth.

RESTRAINT

"High cost of advanced systems"

The average bench top infrared spectroscopy device cost reached USD 36,000 in 2024, compared to USD 14,000 for portable models. Around 41% of small and medium enterprises identified high costs as the main barrier. More than 27% of institutions in low-income regions delayed purchases due to budget constraints. Around 19% of hospitals in Africa and 21% in Southeast Asia reported difficulties financing large-scale purchases. Even in North America, 14% of research institutions chose refurbished equipment. These figures demonstrate cost as a persistent barrier limiting Infrared Spectroscopy Devices Market Adoption globally.

OPPORTUNITY

"Expansion of portable spectroscopy devices"

Portable infrared devices accounted for 39% of global market demand in 2024, equal to 3.0 million units. Around 27% of hospitals globally adopted portable infrared systems for point-of-care diagnostics. Asia-Pacific hospitals accounted for 34% of new portable installations, while Europe accounted for 28% and North America 26%. Around 21% of agricultural firms integrated portable spectroscopy for food safety testing. Portable systems reduced testing times by 32% compared to bench top devices, leading to significant efficiency gains. This expansion highlights one of the strongest Infrared Spectroscopy Devices Market Opportunities for manufacturers.

CHALLENGE

"Lack of technical expertise and training"

Around 27% of hospitals globally reported limited technical training as a barrier to effective device use. More than 19% of pharmaceutical companies stated underutilization of device capabilities due to lack of skilled professionals. Around 21% of research laboratories in Asia-Pacific reported insufficient staff training, impacting operational efficiency. In Europe, 13% of universities noted difficulties in maintaining updated technical expertise. Around 18% of SMEs in Latin America identified lack of trained staff as the reason for delayed adoption. These challenges highlight gaps in technical education that slow down Infrared Spectroscopy Devices Market Growth.

Infrared Spectroscopy Devices Market Segmentation 

The Infrared Spectroscopy Devices Market is segmented by type and application, reflecting distinct usage patterns across industries. Bench top systems dominated with 61% of installations in 2024, equal to 4.8 million units, primarily concentrated in pharmaceutical laboratories where 46% of bench top devices were applied. Portable systems accounted for 39%, or 3.0 million units, with 37% deployed in hospitals for point-of-care diagnostics and 21% used in research laboratories for rapid testing. Hospitals and clinics represented 33% of total demand, equal to 2.6 million units, while the pharmaceutical industry led with 42%, equal to 3.2 million units. Research laboratories accounted for 21%, equal to 1.6 million units, with Asia-Pacific alone representing 34% of this segment.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Bench Top: Bench top devices represented 61% of demand in 2024, equal to 4.8 million units globally. Around 46% of bench top devices were used in pharmaceuticals, 32% in hospitals, and 18% in research laboratories. Europe accounted for 34% of global bench top installations, North America 29%, and Asia-Pacific 28%. Around 17% of bench top devices globally were installed in academic institutions for teaching and research purposes. In the U.S., 39% of hospitals relied on bench top IR devices for diagnostics. Germany accounted for 21% of European bench top installations, highlighting regional leadership in Infrared Spectroscopy Devices Industry Analysis.

The Bench Top segment is valued at USD 877.11 million in 2025 with 65.3% share, projected to reach USD 1417.25 million by 2034 at a CAGR of 5.42%, driven by extensive use in laboratories and pharmaceutical quality assurance.

Top 5 Major Dominant Countries in the Bench Top Segment

• United States market is USD 263.13 million in 2025 with 30% share, expected to reach USD 424.53 million by 2034 at CAGR 5.46%, supported by hospitals and pharmaceutical industries.
• Germany market is USD 96.48 million in 2025 with 11% share, projected to reach USD 155.90 million by 2034 at CAGR 5.41%, driven by clinical diagnostics and R&D labs.
• China market is USD 87.71 million in 2025 with 10% share, forecasted to reach USD 142.05 million by 2034 at CAGR 5.50%, supported by heavy adoption in life sciences.
• Japan market is USD 70.17 million in 2025 with 8% share, projected to hit USD 113.38 million by 2034 at CAGR 5.43%, reflecting investments in advanced healthcare systems.
• France market is USD 61.40 million in 2025 with 7% share, expected to reach USD 99.11 million by 2034 at CAGR 5.45%, boosted by pharmaceutical validations.

Portable: Portable infrared devices represented 39% of demand in 2024, equal to 3.0 million units globally. Around 37% of portable devices were used in hospitals, 29% in pharmaceuticals, and 21% in research labs. Asia-Pacific led portable device adoption with 38% of global installations, while North America contributed 27% and Europe 26%. Around 21% of portable devices globally were used in agricultural and food testing. Around 18% of devices included cloud-enabled features in 2024, and 23% included AI-based enhancements. These statistics reinforce the growing role of portable units in Infrared Spectroscopy Devices Market Forecast.

The Portable segment is valued at USD 466.13 million in 2025 with 34.7% share, projected to reach USD 759.43 million by 2034 at a CAGR of 5.65%, supported by point-of-care diagnostics and field-based applications.

Top 5 Major Dominant Countries in the Portable Segment

• United States market is USD 139.84 million in 2025 with 30% share, projected to reach USD 227.83 million by 2034 at CAGR 5.62%, driven by hospitals and emergency diagnostics.
• China market is USD 93.23 million in 2025 with 20% share, forecasted to hit USD 151.89 million by 2034 at CAGR 5.64%, supported by portable research and food safety testing.
• Japan market is USD 65.26 million in 2025 with 14% share, expected to reach USD 106.32 million by 2034 at CAGR 5.61%, reflecting hospital adoption.
• India market is USD 51.27 million in 2025 with 11% share, projected to hit USD 83.50 million by 2034 at CAGR 5.67%, with demand in clinics and research labs.
• Germany market is USD 41.95 million in 2025 with 9% share, forecasted to reach USD 68.34 million by 2034 at CAGR 5.63%, reflecting clinical demand.

BY APPLICATION

Hospitals and Clinics: Hospitals and clinics represented 33% of demand in 2024, equal to 2.6 million units globally. Around 46% of hospital usage focused on diagnostics, while 29% supported clinical chemistry applications. North America represented 36% of hospital installations, Europe 31%, and Asia-Pacific 28%. Around 19% of hospitals in the Middle East & Africa deployed infrared spectroscopy for patient diagnostics in 2024. More than 27% of hospitals globally invested in portable infrared spectroscopy devices. These numbers highlight healthcare’s significant contribution to Infrared Spectroscopy Devices Market Share.

The Hospitals and Clinics segment is valued at USD 429.84 million in 2025 with 32% share, projected to reach USD 693.94 million by 2034 at CAGR 5.54%, supported by diagnostic and treatment applications.

Top 5 Major Dominant Countries in the Hospitals and Clinics Application

• United States market is USD 128.95 million in 2025 with 30% share, projected to reach USD 208.18 million by 2034 at CAGR 5.56%, reflecting rapid diagnostic adoption.
• Germany market is USD 64.48 million in 2025 with 15% share, expected to hit USD 104.09 million by 2034 at CAGR 5.52%, led by hospital integrations.
• China market is USD 64.48 million in 2025 with 15% share, projected to reach USD 104.09 million by 2034 at CAGR 5.55%, reflecting strong healthcare usage.
• Japan market is USD 47.28 million in 2025 with 11% share, forecasted to hit USD 76.33 million by 2034 at CAGR 5.53%, with adoption in clinical chemistry.
• France market is USD 38.69 million in 2025 with 9% share, projected to reach USD 62.45 million by 2034 at CAGR 5.54%, boosted by diagnostic research.

Pharmaceutical Industry: The pharmaceutical industry accounted for 42% of global demand, equal to 3.2 million units in 2024. Around 58% of these devices were used for drug discovery, while 29% supported quality assurance and regulatory compliance. North America represented 33% of pharmaceutical installations, Europe 29%, and Asia-Pacific 28%. Around 17% of pharmaceutical firms in Asia-Pacific invested in portable IR systems. More than 21% of global device shipments to this sector included AI-driven analysis features. These figures show pharmaceuticals as a central driver in Infrared Spectroscopy Devices Market Growth.

The Pharmaceutical Industry segment is valued at USD 564.16 million in 2025 with 42% share, projected to reach USD 910.21 million by 2034 at CAGR 5.51%, reflecting strong adoption in drug discovery and validation.

Top 5 Major Dominant Countries in the Pharmaceutical Industry Application

• United States market is USD 169.25 million in 2025 with 30% share, projected to reach USD 273.06 million by 2034 at CAGR 5.50%, reflecting dominance in quality assurance.
• China market is USD 112.83 million in 2025 with 20% share, expected to hit USD 182.04 million by 2034 at CAGR 5.52%, supported by generic drug manufacturing.
• Germany market is USD 84.62 million in 2025 with 15% share, projected to reach USD 136.53 million by 2034 at CAGR 5.51%, driven by pharmaceutical exports.
• Japan market is USD 56.42 million in 2025 with 10% share, forecasted to reach USD 91.02 million by 2034 at CAGR 5.53%, reflecting advanced pharma applications.
• India market is USD 39.49 million in 2025 with 7% share, projected to hit USD 63.71 million by 2034 at CAGR 5.54%, reflecting its rising generic medicine base.

Research Laboratories: Research laboratories consumed 21% of devices in 2024, equal to 1.6 million units. Around 47% of research installations were in academic labs, while 34% were in private R&D facilities. Asia-Pacific accounted for 34% of research laboratory demand, Europe 31%, and North America 26%. Around 18% of global research devices incorporated cloud-based features in 2024. More than 22% of labs adopted portable IR spectroscopy to accelerate testing times. These insights highlight the strong role of academic and industrial research in Infrared Spectroscopy Devices Market Analysis.

The Research Laboratories segment is valued at USD 349.24 million in 2025 with 26% share, projected to reach USD 572.53 million by 2034 at CAGR 5.50%, supported by academic and industrial research demand.

Top 5 Major Dominant Countries in the Research Laboratories Application

• United States market is USD 104.77 million in 2025 with 30% share, expected to reach USD 171.77 million by 2034 at CAGR 5.51%, reflecting research leadership.
• China market is USD 69.85 million in 2025 with 20% share, projected to hit USD 114.51 million by 2034 at CAGR 5.52%, supported by R&D investments.
• Japan market is USD 52.39 million in 2025 with 15% share, forecasted to reach USD 85.88 million by 2034 at CAGR 5.50%, led by university labs.
• Germany market is USD 41.91 million in 2025 with 12% share, expected to hit USD 68.70 million by 2034 at CAGR 5.49%, reflecting academic R&D centers.
• India market is USD 27.94 million in 2025 with 8% share, projected to reach USD 45.80 million by 2034 at CAGR 5.51%, reflecting government-backed research.

Infrared Spectroscopy Devices Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

The Infrared Spectroscopy Devices Market shows clear regional diversification, with Asia-Pacific leading global demand at 29% in 2024, equal to 2.3 million units, supported by China’s 42% regional share and India’s 18% share in pharmaceutical research. Europe accounted for 27% of installations, or 2.1 million units, with Germany contributing 31% of regional usage, France 21%, and the United Kingdom 17%, driven largely by hospital diagnostics. North America represented 25% of demand, or 1.9 million units, where the United States dominated with 68% of regional share, Canada 19%, and Mexico 8%, reflecting strong adoption in pharmaceutical and hospital applications. The Middle East & Africa contributed 19% of demand, or 0.9 million units, with Saudi Arabia accounting for 29% of the region, UAE 23%, and South Africa 18%, supported by usage in healthcare and oil and gas industries

North America

The North America Infrared Spectroscopy Devices Market accounted for 25% of global demand in 2024, equal to nearly 1.9 million installed units. The United States dominated with 68% of this volume, representing 1.3 million devices, followed by Canada with 19% at 361,000 units and Mexico with 8% at 152,000 units. Cuba and the Dominican Republic together added around 95,000 units, making up 5% of the region. Around 43% of all devices in North America were applied in pharmaceuticals, equal to 817,000 units, while 32% were installed in hospitals and clinics, equal to 608,000 units. Research laboratories accounted for 19%, or 361,000 devices, with strong adoption in both public and private institutions. Bench top systems represented 64% of the regional market with 1.2 million units, while portable devices accounted for 684,000 units.

The North America market is valued at USD 335.81 million in 2025 with 25% share, projected to reach USD 543.86 million by 2034 at CAGR 5.49%, supported by hospitals, pharmaceuticals, and advanced research adoption.

North America - Major Dominant Countries

• United States market is USD 228.35 million in 2025 with 68% share, projected to reach USD 369.83 million by 2034 at CAGR 5.50%.
• Canada market is USD 63.80 million in 2025 with 19% share, forecasted to hit USD 103.33 million by 2034 at CAGR 5.47%.
• Mexico market is USD 26.86 million in 2025 with 8% share, projected to reach USD 43.51 million by 2034 at CAGR 5.50%.
• Cuba market is USD 8.39 million in 2025 with 2.5% share, expected to hit USD 13.59 million by 2034 at CAGR 5.48%.
• Dominican Republic market is USD 8.39 million in 2025 with 2.5% share, forecasted to reach USD 13.59 million by 2034 at CAGR 5.48%.

Europe

Europe accounted for 27% of global demand in 2024, equal to 2.1 million installed units. Germany led the region with 31% share, or 651,000 units, followed by France with 21% at 441,000 units, the United Kingdom with 17% at 357,000 units, Italy with 13% at 273,000 units, and Spain with 12% at 252,000 units. Around 46% of all infrared devices in Europe were used in hospitals and clinics, equal to 966,000 units, while 29% supported pharmaceutical applications, equal to 609,000 units. Research laboratories consumed 19%, or nearly 399,000 devices, largely within academic institutions. Bench top models made up 66% of the European total, equal to 1.4 million units, while portable systems represented 34%, equal to 714,000 units.

The Europe market is valued at USD 362.67 million in 2025 with 27% share, projected to reach USD 587.70 million by 2034 at CAGR 5.51%, reflecting strong pharmaceutical and hospital demand.

Europe - Major Dominant Countries

• Germany market is USD 112.43 million in 2025 with 31% share, forecasted to reach USD 182.19 million by 2034 at CAGR 5.49%.
• France market is USD 76.16 million in 2025 with 21% share, projected to hit USD 123.41 million by 2034 at CAGR 5.50%.
• United Kingdom market is USD 61.65 million in 2025 with 17% share, forecasted to hit USD 99.79 million by 2034 at CAGR 5.52%.
• Italy market is USD 47.15 million in 2025 with 13% share, expected to reach USD 76.34 million by 2034 at CAGR 5.49%.
• Spain market is USD 43.52 million in 2025 with 12% share, projected to reach USD 70.93 million by 2034 at CAGR 5.50%.

Asia-Pacific

The Asia-Pacific Infrared Spectroscopy Devices Market was the largest globally, representing 29% of demand in 2024, equal to 2.3 million installed units. China accounted for 42% of this regional demand, or 966,000 units, followed by Japan with 21% at 483,000 units, India with 18% at 414,000 units, South Korea with 12% at 276,000 units, and Australia with 7% at 161,000 units. Around 36% of Asia-Pacific demand was from research laboratories, equal to 828,000 units, while 34% came from pharmaceuticals, equal to 782,000 units. Hospitals and clinics contributed 26%, or 598,000 devices. Portable devices represented 41% of the regional market, equal to 943,000 units, while bench top systems accounted for 59%, or 1.36 million units.

The Asia market is valued at USD 389.54 million in 2025 with 29% share, projected to reach USD 629.24 million by 2034 at CAGR 5.53%, supported by R&D growth, pharmaceuticals, and hospital integrations.

Asia - Major Dominant Countries

• China market is USD 163.61 million in 2025 with 42% share, projected to reach USD 263.48 million by 2034 at CAGR 5.54%.
• Japan market is USD 81.80 million in 2025 with 21% share, forecasted to hit USD 131.74 million by 2034 at CAGR 5.52%.
• India market is USD 70.12 million in 2025 with 18% share, projected to reach USD 112.36 million by 2034 at CAGR 5.53%.
• South Korea market is USD 46.75 million in 2025 with 12% share, forecasted to hit USD 74.92 million by 2034 at CAGR 5.51%.
• Australia market is USD 27.27 million in 2025 with 7% share, projected to reach USD 43.74 million by 2034 at CAGR 5.50%.

Middle East & Africa

The Middle East & Africa Infrared Spectroscopy Devices Market represented 19% of global demand in 2024, equal to 0.9 million installed units. Saudi Arabia led with 29% of regional demand, or 261,000 devices, followed by the UAE with 23% at 207,000 units, South Africa with 18% at 162,000 units, Egypt with 17% at 153,000 units, and Nigeria with 13% at 117,000 units. Around 34% of devices in this region were installed in hospitals, equal to 306,000 units, while 27% were used in pharmaceuticals, equal to 243,000 units. Research applications accounted for 20%, or 180,000 units, and oil and gas accounted for 19%, or 171,000 units. Bench top models represented 62% of demand, equal to 558,000 units, while portable devices accounted for 38%, or 342,000 units.

The Middle East and Africa market is valued at USD 255.22 million in 2025 with 19% share, projected to reach USD 415.87 million by 2034 at CAGR 5.49%, reflecting demand from hospitals and oilfield testing.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia market is USD 74.01 million in 2025 with 29% share, projected to reach USD 120.61 million by 2034 at CAGR 5.50%.
• United Arab Emirates market is USD 58.71 million in 2025 with 23% share, forecasted to hit USD 95.65 million by 2034 at CAGR 5.48%.
• South Africa market is USD 45.94 million in 2025 with 18% share, projected to hit USD 74.02 million by 2034 at CAGR 5.50%.
• Egypt market is USD 43.39 million in 2025 with 17% share, expected to reach USD 69.89 million by 2034 at CAGR 5.49%.
• Nigeria market is USD 33.18 million in 2025 with 13% share, projected to reach USD 53.69 million by 2034 at CAGR 5.50%.

List of Top Infrared Spectroscopy Devices Companies

• Agilent Technologies
• Thermo Fisher Scientific
• Jasco
• Shimadzu
• PerkinElmer
• Bruker
• Princeton Instruments
• Sartorius

Top Two Companies With Highest Share

• Agilent Technologies – Held 15% global share in 2024, with more than 1.1 million units installed across pharmaceuticals, hospitals, and laboratories.
• Thermo Fisher Scientific – Accounted for 14% share, deploying over 1.0 million units globally, with strong adoption in diagnostics and life sciences.

Investment Analysis and Opportunities

Global investments in infrared spectroscopy devices exceeded 4.1 million new installations in 2024. Around 39% of investments targeted hospitals, 32% pharmaceuticals, and 21% research laboratories. Asia-Pacific attracted 34% of total investments, Europe 29%, North America 25%, and Middle East & Africa 12%. Around 27% of new investment flowed into portable IR devices, reducing testing times by 32%. More than 19% of funds supported AI-based features, and 16% supported cloud-enabled models. Pharmaceutical industry investments represented 42% of total funds, equaling 1.7 million units. These statistics highlight significant Infrared Spectroscopy Devices Market Opportunities in healthcare, diagnostics, and advanced research.

New Product Development

Between 2023 and 2024, more than 620,000 new infrared spectroscopy devices were launched. Around 38% were portable models targeting hospitals, 26% integrated AI features, 22% focused on pharmaceutical applications, and 14% targeted research laboratories. Miniaturization advances reduced average device weight by 28%, while detection accuracy improved by 21%. Around 19% of new models incorporated connectivity features for remote operation. In Europe, more than 17% of new product launches were directed toward hospital diagnostic tools. In Asia-Pacific, 22% of new devices targeted research labs, with China leading. These facts confirm innovation as a major contributor to Infrared Spectroscopy Devices Market Growth.

Five Recent Developments

• Agilent launched a portable infrared device adopted by 18% of hospitals in North America, reducing diagnostic times by 22%.
• Thermo Fisher introduced AI-enabled spectroscopy software used by 14% of pharmaceutical companies globally for faster drug analysis.
• Shimadzu developed compact infrared models installed by 23% of Japanese research institutions, improving portability and efficiency.
• Bruker introduced cloud-enabled devices adopted by 19% of European hospitals for real-time diagnostics.
• PerkinElmer launched miniaturized portable IR devices used by 17% of agricultural companies for food safety testing.

Report Coverage of Infrared Spectroscopy Devices Market

This Infrared Spectroscopy Devices Market Report covers global demand, segmentation, and regional performance across more than 7.8 million installed units in 2024. Bench top devices accounted for 61% and portable devices 39% of demand. Applications were led by pharmaceuticals with 42% share, hospitals with 33%, and research laboratories with 21%. Asia-Pacific led with 29% of demand, followed by Europe at 27%, North America at 25%, and Middle East & Africa at 19%. Around 34% of investments targeted portable IR devices, 27% AI-driven upgrades, and 16% cloud integration. The report provides Infrared Spectroscopy Devices Market Analysis, Market Trends, Market Size, Market Share, Market Forecast, and Market Insights, supporting strategies for stakeholders in healthcare, pharmaceuticals, and advanced research.

Infrared Spectroscopy Devices Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1417.33 Million in 2026
Market Size Value By	USD 2306.34 Million by 2035
Growth Rate	CAGR of 5.51% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Bench Top Portable By Application : Hospitals and Clinics Pharmaceutical Industry Research Laboratories
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample